BBB National Programs Decision Summaries
BBB National Programs provides summaries of all case decisions from the National Advertising Division (NAD), National Advertising Review Board (NARB), Children’s Advertising Review Unit (CARU), Direct Selling Self-Regulatory Council (DSSRC), and Digital Advertising Accountability Program (DAAP). Subscribe to receive a weekly wrap-up of published case decisions in your inbox.
- All
-
3/16/2023 - National Advertising Review Board Recommends American Beverage Association Modify Certain Environmental Benefit Claims for “Every Bottle Back” Initiative
New York, NY – March 16, 2023 – A panel of the National Advertising Review Board (NARB) recommended that the American Beverage Association (ABA) modify certain aspirational claims regarding the use of recycled materials in bottles, as well as claims relating to ABA’s partnerships with non-profit organizations and efforts to achieve sustainability goals.
-
3/08/2023 - National Advertising Review Board Recommends SharkNinja Discontinue or Modify Certain Claims for Shark Air Purifiers
New York, NY – March 8, 2023 – A panel of the National Advertising Review Board (NARB) recommended that SharkNinja discontinue claims that its Shark Air Purifier 6 meets or exceeds HEPA standards and that its air purifiers perform better than other HEPA-labeled air purifiers, and recommended they modify its “Clean Air 100%” claim.
-
2/14/2023 - National Advertising Review Board Recommends Genexa Discontinue or Modify Pediatrician Preference and Ingredient Claims for “Kids’ Pain & Fever” Medicine
New York, NY – February 14, 2023 – A panel of the National Advertising Review Board (NARB) recommended that Genexa discontinue certain pediatrician preference claims and ingredient claims for its acetaminophen-based children’s analgesic sold over the counter as “Kids’ Pain & Fever.”
-
2/06/2023 - National Advertising Review Board Finds WhatsApp Encryption Messaging Claims Supported
New York, NY – February 6, 2023 – A panel of the National Advertising Review Board (NARB), the appellate advertising law body of BBB National Programs, determined that WhatsApp, LLC provided a reasonable basis for two express claims for its WhatsApp messaging service analogizing SMS text messages to “open mail” as used in the advertiser’s television commercial titled “Doubt Delivered.”
-
11/02/2022 - National Advertising Review Board Finds Sanofi’s “#1 Doctor Recommended Ingredient” Claims for Zantac 360° Unsubstantiated
New York, NY – November 2, 2022 – A panel of the National Advertising Review Board (NARB), the appellate advertising law body of BBB National Programs, recommended that Sanofi Consumer Healthcare not use claims that Zantac 360° contains, or that famotidine is, “the #1 Doctor Recommended ingredient” or “the #1 Doctor Recommended ingredient among H2 Blockers.”
-
10/20/2022 - NARB Finds Glee Gum’s “Plant-Based,” “Made with Chicle,” “Natural,” Claims Supported; Recommends Discontinuance of “Plastic Free” Claims
New York, NY – October 20, 2022 – A panel of the National Advertising Review Board (NARB), the appellate advertising decision body of BBB National Programs, has determined that Mazee, LLC has reasonable support for claims that its Glee Gum is “plant-based,” “made with chicle,” and “natural.” However, the NARB Panel recommended that the advertiser discontinue claims that Glee Gum is “plastic-free.”
-
9/15/2022 - National Advertising Review Board Recommends P&G Discontinue Odor Elimination Claims for Febreze Products
New York, NY – September 15, 2022 – A panel of the National Advertising Review Board (NARB) recommended that P&G discontinue certain “odor elimination” claims that P&G makes across its Febreze line of home fragrance products, which include the Febreze air, candle, car, plug, small spaces, and wax melts products.
-
8/24/2022 - National Advertising Review Board Recommends CoStar Group Discontinue Apartments.com Claim “The Most Popular Place to Find a Place”
New York, NY – August 24, 2022 – A panel of the National Advertising Review Board (NARB), the appellate advertising law body of BBB National Programs, recommended that CoStar Group, Inc. discontinue the claim “The Most Popular Place to Find a Place” and that it modify certain advertising to make clear that it is directed only to the rental market.
-
5/05/2022 - National Advertising Review Board Recommends Merck Animal Health Discontinue “Best in Show” Commercial for Bravecto Flea and Tick Preventative for Dogs
New York, NY – May 05, 2022 – A panel of the National Advertising Review Board (NARB) has recommended that Merck Animal Health discontinue its “Best in Show” commercial for Bravecto brand flea and tick preventative based on the NARB panel’s finding that the 30-second commercial reasonably communicates an implied misleading and unsupported message that a rival company’s NexGard brand flea preventative fails to protect against fleas for twelve weeks because of a lack of efficacy.
-
4/27/2022 - National Advertising Review Board Finds Goli Nutrition’s “Apple Cider Vinegar” Gummies Product Name Supported and Not Misleading
New York, NY – April 27, 2022 – A panel of the National Advertising Review Board (NARB), the appellate advertising law body of BBB National Programs, has determined that Goli Nutrition, Inc. supported its express use of the term “Apple Cider Vinegar” in the product name of its Apple Cider Vinegar (ACV) Gummies dietary supplement.